Cutler Group’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Cutler Group’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,500	Closed	-$20K	–	5028
2019 Q2	$20K	Buy	+5,500	New	+$52.3K	﹤0.01%	2236
2018 Q4	–	Sell	-4,300	Closed	-$3K	–	4958
2018 Q3	$3K	Buy	4,300 +600	+16%	+$14.3K	﹤0.01%	3423
2018 Q2	$30K	Buy	+3,700	New	+$101K	﹤0.01%	1938

Cutler Group's DOVA Position: Q4 2019 in Review

Cutler Group sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 3,500 shares — an estimated $97K sold.

Cutler Group first reported a position in DOVA in Q4 2018 and held it in 3 quarters. The position peaked at $97K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Cutler Group reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Cutler Group sold 3,500 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $97K.
Cutler Group first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 3 quarters.
Cutler Group's Dova Pharmaceuticals, Inc. Common Stock position peaked at $97K in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Cutler Group's 13F filing for Q4 2019, filed 6 Feb 2020.